在患有毛状细胞白血病的患者中静脉血栓栓塞
Lauren Peralta1, Muneer Khan2, Marcelle G Meseeha2
1Integrative Neuroscience Program, Binghamton University, Binghamton, NY, USA.
Hematology (Amsterdam, Netherlands)
|November 27, 2024
概括
患有毛细胞白血病 (HCL) 的患者有很高的静脉血栓塞栓症 (VTE) 发病率. 这表明,即使没有其他危险因素,HCL本身也可能导致前血栓状况.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 血栓形成研究研究
背景情况:
- 毛细胞白血病 (HCL) 是一种罕见的成熟B细胞白血病,占淋巴瘤新生体的2%.
- 癌症和静脉血栓栓塞 (VTE) 之间的联系是已知的,但HCL中的VTE缺乏系统研究.
研究的目的:
- 为了确定HCL患者中VTE的患病率.
- 在这个人群中确定与VTE相关的风险因素.
主要方法:
- 从56名HCL患者 (1998-2023) 的医疗记录的回顾性审查.
- 分析VTE发作,类型 (肺栓塞,深静脉血栓塞) 和同时发生的危险因素.
主要成果:
- 14%的HCL患者经历了静脉动脉突发症 (8名患者中发生了11次).
- 静脉动脉突发症与HCL诊断同时或之后发生,通常是最初的表现.
- 其他VTE风险因素仅在3名患者中存在.
结论:
- HCL与高发动性静脉瘤有关.
- 这些发现表明,HCL中存在固有的血栓性状态,独立于其他危险因素.
相关概念视频
Disorders of Hemostasis
710
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
710
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Bone Marrow Sampling and Transplants
284
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
284


